Key result
Mexidol demonstrated high effectiveness in the complex correction and prevention of manifestations of autonomic dysfunction syndromes and concomitant neuropsychiatric disorders in children.
Why the study?
The diagnosis and treatment of children with autonomic dysfunction syndromes remains an important clinical problem.
Does Mexidol improve manifestations of autonomic dysfunction syndromes and concomitant neuropsychiatric disorders in children and adolescents?
Does Mexidol improve manifestations of autonomic dysfunction syndromes and concomitant neuropsychiatric disorders in children and adolescents?
This review highlights the pathogenesis and clinical manifestations of autonomic dysfunction in children and supports the use of Mexidol for its management.
The article is devoted to the important problem of diagnosis and treatment of children with autonomic dysfunction syndromes (SVD). Information is provided on the evolution of views on the pathogenesis of this condition. The issues of pathogenesis, classification and clinical manifestations of SVD in children and adolescents are covered in detail. The high effectiveness of the use of Mexidol in the complex correction and prevention of manifestations of SVD, as well as concomitant neuropsychiatric disorders in children and adolescents has been demonstrated.
No takes yet. Share an insight, caveat, or question.
С А Немкова (2024) conducted a review in Autonomic dysfunction syndromes (SVD). Mexidol was evaluated on Correction and prevention of manifestations of SVD and concomitant neuropsychiatric disorders. Mexidol demonstrated high effectiveness in the complex correction and prevention of manifestations of autonomic dysfunction syndromes and concomitant neuropsychiatric disorders in children.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: